Published in Hepatology on March 18, 1985
Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology (2008) 1.71
Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol (2006) 1.17
Nutritional support: how much for how much? Gut (1986) 0.91
Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials. World J Gastroenterol (2010) 0.79
Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res (2016) 0.77
Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. Ger Med Sci (2009) 0.76
Advances in alcoholic liver disease: An update on alcoholic hepatitis. World J Gastroenterol (2015) 0.75
Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med (2000) 5.13
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Leptin regulates proinflammatory immune responses. FASEB J (1998) 4.31
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med (1989) 4.07
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg (1991) 3.88
Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A (1997) 3.79
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A (1997) 3.59
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A (1993) 3.33
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
Animal models of steatosis. Semin Liver Dis (2001) 2.88
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol (2000) 2.83
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol (1992) 2.33
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med (1989) 2.28
The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut (2008) 2.26
Sex differences in gastric alcohol dehydrogenase activity in Sprague-Dawley rats. Gastroenterology (1992) 2.16
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology (2001) 2.14
Sampling variability on percutaneous liver biopsy. Arch Intern Med (1979) 2.12
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA (1999) 2.12
Cloning of a serotonin transporter affected by antidepressants. Science (1991) 2.12
Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem (1996) 2.11
Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology (2000) 2.10
Aging and ethanol metabolism. Clin Pharmacol Ther (1977) 1.99
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 1.94
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) (1970) 1.82
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78
Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents. Surgery (1983) 1.77
Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys (2000) 1.74
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology (1993) 1.68
Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet (1997) 1.65
Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology (2000) 1.63
Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett (1986) 1.62
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther (2004) 1.61
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Vessel caliber and branch-angle of human coronary artery branch-points. Circ Res (1976) 1.55
Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol (1994) 1.55
Nonketotic hyperglycemia appearing as choreoathetosis or ballism. Arch Intern Med (1982) 1.54
The national 5 A Day for Better Health Program: a large-scale nutrition intervention. J Public Health Manag Pract (1996) 1.54
Isoniazid hepatitis. Ann Intern Med (1973) 1.51
TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci (1999) 1.49
Carcinoma of the body and tail of the pancreas. Am J Surg (1992) 1.48
Vasopressin and oxytocin mRNAs in adrenalectomized and Brattleboro rats: analysis by quantitative in situ hybridization histochemistry. Brain Res (1986) 1.47
More rapid elimination of alcohol in women as compared to their male siblings. Alcohol Clin Exp Res (1989) 1.47
Diet and other risk factors for cancer of the pancreas. Cancer (1985) 1.47
Septic arthritis caused by Propionibacterium acnes. JAMA (1982) 1.45
Spectrum of cystic tumors of the pancreas. Am J Surg (1992) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology (1994) 1.43
Stress and ethanol metabolism. Alcohol Alcohol (1998) 1.42
Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res (2001) 1.42
Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42
Ischemic hepatitis. Dig Dis Sci (1979) 1.41
Fulminant hepatitis complicated by pancreatitis. Johns Hopkins Med J (1973) 1.40
Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver (2000) 1.39
Trauma in cirrhosis: an indicator of the pattern of alcohol abuse in different societies. Alcohol Clin Exp Res (1991) 1.38
Quantitative histological analysis of the cerebellar nuclei in the cat. I. Numerical data on cells and on synapses. Exp Brain Res (1977) 1.37
Vitamin A and zinc therapy in primary biliary cirrhosis. Hepatology (1981) 1.36
Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology (1999) 1.34
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33
Intestinal malabsorption in folate-deficient alcoholics. Gastroenterology (1973) 1.33
Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol (1999) 1.32
Dietary behavior change: the challenge of recasting the role of fruit and vegetables in the American diet. Am J Clin Nutr (1995) 1.32
Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A (1998) 1.31
Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci U S A (1995) 1.31
Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol (2003) 1.31
Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med (1981) 1.29
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience (1998) 1.28
Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun (1998) 1.28
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology (1999) 1.27
A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.27
The liver in mild halothane hepatitis. Light and electron microscopic findings with special reference to the mononuclear cell infiltrate. Am J Pathol (1970) 1.25
Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol (1996) 1.25
Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res (1987) 1.24
Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab (1997) 1.24
Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2013) 1.23
Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J Biol Chem (1996) 1.22
Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem (1998) 1.22
Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats. Am J Physiol (1998) 1.21
Cytokines and alcoholic liver disease. Semin Liver Dis (1993) 1.20
Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol (1998) 1.20
Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) (2007) 1.18
Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology (1995) 1.18
The upstream stimulatory factor binds to and activates the promoter of the rat class I alcohol dehydrogenase gene. J Biol Chem (1991) 1.17
Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol (2001) 1.16
Drug-induced chronic liver disease. Gastroenterology (1977) 1.16
Lethal tricuspid and mitral regurgitation in Marfan's syndrome. Am J Cardiol (1967) 1.16
Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res (1998) 1.15
Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci U S A (1991) 1.15
Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett (1989) 1.15
Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology (1977) 1.15
Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology (1997) 1.14
Pancreatic function and intestinal absorption in chronic alcoholism. Gastroenterology (1970) 1.14
Innervation of the nucleus of the solitary tract and the dorsal vagal nucleus by thyrotropin-releasing hormone-containing raphe neurons. Brain Res (1986) 1.14
Distribution of ethanol in the human gastrointestinal tract. Am J Clin Nutr (1973) 1.13